Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

NCT02939014

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Sun Yat-san University Cancer Center Guangzhou, Guangdong, China
  • Jiangsu Cancer Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)

NCT02593045

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • Ohio State University Columbus, Ohio, United States
  • Hôpital Saint-Louis Paris, France
  • Leiden University Medical Center Leiden, Netherlands
View Trial Details
Completed

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

NCT01578499

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Chicago, Illinois, United States
  • Boston, Massachusetts, United States
View all 41 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

NCT02580552

Conditions
Adult T-Cell Leukemia/Lymphoma (ATLL), Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +29 more
Locations
  • City of Hope Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center at University of California, Irvine Orange, California, United States
View all 19 locations
View Trial Details

Related conditions